Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1041

1.
2.

[Progress in the prevention of type 2 diabetes].

Schernthaner G.

Wien Klin Wochenschr. 2003 Nov 28;115(21-22):745-57. Review. German.

PMID:
14743578
3.

Systematic review of the long-term effects and economic consequences of treatments for obesity and implications for health improvement.

Avenell A, Broom J, Brown TJ, Poobalan A, Aucott L, Stearns SC, Smith WC, Jung RT, Campbell MK, Grant AM.

Health Technol Assess. 2004 May;8(21):iii-iv, 1-182. Review.

4.

Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention.

Unwin N, Shaw J, Zimmet P, Alberti KG.

Diabet Med. 2002 Sep;19(9):708-23. Review.

PMID:
12207806
5.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
6.

Oral antidiabetic agents: current role in type 2 diabetes mellitus.

Krentz AJ, Bailey CJ.

Drugs. 2005;65(3):385-411. Review.

PMID:
15669880
7.

The prevention of type 2 diabetes: what is the evidence?

Chiasson JL, Brindisi MC, Rabasa-Lhoret R.

Minerva Endocrinol. 2005 Sep;30(3):179-91. Review.

PMID:
16208307
9.

Insulin therapy in type 2 diabetes.

Mudaliar S, Edelman SV.

Endocrinol Metab Clin North Am. 2001 Dec;30(4):935-82. Review.

PMID:
11727406
10.

Impaired glucose tolerance: is there a case for pharmacologic intervention?

Costa A, Conget I, Gomis R.

Treat Endocrinol. 2002;1(4):205-10. Review.

PMID:
15799213
11.

Gestational diabetes mellitus and subsequent development of overt diabetes mellitus.

Damm P.

Dan Med Bull. 1998 Nov;45(5):495-509. Review.

PMID:
9850811
12.

Prevention of type 2 diabetes: are we ready?

Bouche C, Goldfine AB.

Minerva Med. 2003 Feb;94(1):9-18. Review.

PMID:
12719698
13.

Reflecting on type 2 diabetes prevention: more questions than answers!

Rosenstock J.

Diabetes Obes Metab. 2007 Sep;9 Suppl 1:3-11. Review.

PMID:
17877541
14.

Exercise in the management of non-insulin-dependent diabetes mellitus.

Wallberg-Henriksson H, Rincon J, Zierath JR.

Sports Med. 1998 Jan;25(1):25-35. Review. Erratum in: Sports Med 1998 Feb;25(2):130.

PMID:
9458525
15.

Prevention of type 2 diabetes.

Lai LC.

Malays J Pathol. 2002 Dec;24(2):71-6. Review.

PMID:
12887163
16.

[Drug therapy in subjects with impaired glucose tolerance].

Kawamori R, Yoshii H.

Nihon Rinsho. 1996 Oct;54(10):2750-3. Review. Japanese.

PMID:
8914439
17.

Type 2 diabetes mellitus: the grand overview.

Ratner RE.

Diabet Med. 1998;15 Suppl 4:S4-7. Review.

PMID:
9868984
18.

Therapeutic implications of diabetes in cardiovascular disease.

Cherian B, Meka N, Katragadda S, Arora R.

Am J Ther. 2009 Nov-Dec;16(6):e51-9. doi: 10.1097/MJT.0b013e31815db924. Review.

PMID:
19940606
19.

The potential of metformin for diabetes prevention.

Slama G.

Diabetes Metab. 2003 Sep;29(4 Pt 2):6S104-11. Review.

PMID:
14502107
20.

[Cardiovascular risk and cardiometabolic risk: an epidemiological evaluation].

Vanuzzo D, Pilotto L, Mirolo R, Pirelli S.

G Ital Cardiol (Rome). 2008 Apr;9(4 Suppl 1):6S-17S. Review. Italian.

PMID:
18773746

Supplemental Content

Support Center